newsfilter
← Latest News
GlobeNewswire·

Progenics Pharmaceuticals Appoints David Mims as Interim Chief Executive Officer

NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and...